Oregon Public Employees Retirement Fund’s Allogene Therapeutics ALLO Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio ALLO Stock Details ALLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-39,456	Closed	-$359K	–	1542
2022 Q1	$359K	Hold	39,456	–	–	﹤0.01%	1493
2021 Q4	$589K	Hold	39,456	–	–	0.01%	1241
2021 Q3	$1.01M	Hold	39,456	–	–	0.01%	984
2021 Q2	$1.03M	Hold	39,456	–	–	0.01%	1013
2021 Q1	$1.39M	Hold	39,456	–	–	0.02%	801
2020 Q4	$996K	Sell	39,456 -5,000	-11%	-$163K	0.01%	920
2020 Q3	$1.68M	Buy	+44,456	New	+$1.68M	0.02%	544

Other funds holding ALLO

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Oregon Public Employees Retirement Fund's ALLO Position: Q2 2022 in Review

Oregon Public Employees Retirement Fund sold out of Allogene Therapeutics (ALLO) in Q2 2022, closing a stake of 39,456 shares — an estimated $359K sold.

Oregon Public Employees Retirement Fund first reported a position in ALLO in Q3 2020 and held it in 7 quarters. The position peaked at $1.68M in Q3 2020. 161 funds tracked by Wall St. Rank hold ALLO as of Q2 2022.

Oregon Public Employees Retirement Fund reported no remaining Allogene Therapeutics position as of Q2 2022 after selling out during the quarter.
Oregon Public Employees Retirement Fund sold 39,456 Allogene Therapeutics shares in Q2 2022, an estimated $359K.
Oregon Public Employees Retirement Fund first reported a position in Allogene Therapeutics in Q3 2020 and held it in 7 quarters.
Oregon Public Employees Retirement Fund's Allogene Therapeutics position peaked at $1.68M in Q3 2020.
161 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2022.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2022, filed 25 Jul 2022.